5255 Yonge Street
Suite 701
Toronto, ON M2N 6P4
Canada
416 840 3725
https://mpxinternationalcorp.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. William Scott Boyes BA, MBA | Chairman, President & CEO | 120,14k | N/A | 1951 |
Mr. Jeremy Daniel Daniel Blumer | CFO & Director | 149,45k | N/A | N/A |
Mr. Jeremy S. Budd | Executive VP, General Counsel. Corporate Secretary & Director | 148,43k | N/A | 1979 |
Richard Montcalm | Director of Marketing | N/A | N/A | N/A |
Mr. Michael Arnkvarn | Chief Operating Officer of Canada | N/A | N/A | N/A |
MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.
MPX International Corporations ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.